Fulgent Genetics: Soars on Q4 results beat, upbeat FY21 forecast

Fulgent Genetics

05/03/2021 10:01

** Shares of genetic testing co  FLGT.O  up 26.3% at $108
pre-market
    ** Co reports Q4 adjusted earnings of $6.20​​/shr, beating
analysts' estimate of profit of $4.05/shr - Refinitiv IBES
 urn:newsml:reuters.com:*:nASA01UE9
    ** Co posts Q4 revenue of $294.98 mln, above analysts'
expectation of $199.44 mln, helped by strong demand in COVID-19
testing
    ** FLGT sees FY21 revenue of about $800 mln, above estimates
of $600.2 mln 
    ** At least two brokerages raised their PTs for stock
    ** Up to Thursday's close, stock had risen 64% YTD

 (Reporting by Sahil Shaw in Bengaluru)
 ((sahil.shaw@thomsonreuters.com))